Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Bath & Body Works (NYSE:BBWI - Get Rating) issued an update on its third quarter 2022 earnings guidance on Wednesday morning. The company provided EPS guidance of $0.10-$0.20 for the period, compared to the consensus EPS estimate of $0.35. The company issued revenue guidance of -. Bath & Body Works also updated its FY 2022 guidance to $2.70-$3.00 EPS.Bath & Body Works Stock Down 3.0 %

BBWI stock opened at $37.31 on Wednesday. Bath & Body Works has a 52 week low of $25.75 and a 52 week high of $82.00. The stock has a market capitalization of $8.53 billion, a P/E ratio of 9.90, a P/E/G ratio of 0.92 and a beta of 1.77. The firm has a 50-day simple moving average of $33.60 and a 200-day simple moving average of $42.30.

Bath & Body Works (NYSE:BBWI - Get Rating) last released its earnings results on Wednesday, August 17th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.41 by $0.11. The business had revenue of $1.62 billion during the quarter, compared to analyst estimates of $1.61 billion. Bath & Body Works had a net margin of 12.31% and a negative return on equity of 57.40%. The company's revenue for the quarter was down 5.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.34 earnings per share. On average, analysts expect that Bath & Body Works will post 2.88 earnings per share for the current year. Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, September 2nd. Stockholders of record on Friday, August 19th were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a dividend yield of 2.14%. The ex-dividend date of this dividend was Thursday, August 18th. Bath & Body Works's payout ratio is presently 21.22%. Analyst Upgrades and Downgrades

Several equities analysts have recently commented on BBWI shares. Credit Suisse Group decreased their price target on Bath & Body Works from $49.00 to $42.00 and set a neutral rating on the stock in a research note on Thursday, August 18th. Robert W. Baird raised their price target on Bath & Body Works from $40.00 to $48.00 and gave the stock an outperform rating in a research report on Thursday, August 18th. JPMorgan Chase & Co. cut Bath & Body Works from an overweight rating to a neutral rating and lowered their target price for the company from $63.00 to $30.00 in a report on Wednesday, June 29th. Telsey Advisory Group boosted their price target on shares of Bath & Body Works from $40.00 to $52.00 and gave the stock an outperform rating in a research note on Thursday, August 18th. Finally, Raymond James lifted their price objective on shares of Bath & Body Works from $43.00 to $48.00 and gave the company a strong-buy rating in a report on Friday, August 19th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of Moderate Buy and an average price target of $53.05.Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Walleye Capital LLC lifted its position in Bath & Body Works by 167.2% in the second quarter. Walleye Capital LLC now owns 15,200 shares of the company's stock worth $409,000 after purchasing an additional 9,511 shares during the period. National Pension Service raised its position in Bath & Body Works by 14.6% in the second quarter. National Pension Service now owns 103,265 shares of the company's stock worth $2,780,000 after acquiring an additional 13,166 shares in the last quarter. First Republic Investment Management Inc. acquired a new stake in Bath & Body Works in the 2nd quarter valued at about $212,000. Captrust Financial Advisors lifted its holdings in Bath & Body Works by 24.6% in the 2nd quarter. Captrust Financial Advisors now owns 3,892 shares of the company's stock valued at $105,000 after acquiring an additional 768 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in shares of Bath & Body Works by 8.2% during the 2nd quarter. Price T Rowe Associates Inc. MD now owns 6,364,253 shares of the company's stock valued at $171,326,000 after purchasing an additional 484,674 shares in the last quarter. Institutional investors own 96.19% of the company's stock. Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.See AlsoGet a free copy of the StockNews.com research report on Bath & Body Works (BBWI)3 Low Beta Defensive Stocks for a Tough MarketIt Could Be a September to Remember for These 3 StocksCan Roblox Reverse its Falling Bookings Amid Rising EngagementsPeak Inflation Sets the Bottom for Brinker International Stock Broadcom Bounces From Institutional Bottom 

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Bath & Body Works, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.

While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Michael Wang of Prometheus Alternative Investments discusses how individuals should approach their portfolios as the summer rally seems to have fizzled.

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

Twitter Facebook StockTwits Financial Juice YouTube

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved. 326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257 MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.